Assistance Publique - Hôpitaux de Paris: Coronavirus Infections trials
The registry lists 10 Coronavirus Infections studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 2 5Phase 3 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- ELderly REspiratory VIral CohortNot yet recruitingNCT07813481
- CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 InfectionCompletedNCT04341584Phase 2Results posted
- CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)CompletedNCT04331808Phase 2Results posted
- Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARICompletedNCT04324073Phase 2/3Results posted
- EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
- Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19CompletedNCT04476979Phase 2
- COVID-19 Infection and Transmission in Exposed, Confined and Community-based InfantsCompletedNCT04413968Not applicable
- Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)Status unknownNCT04355429Phase 2
- Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare ProvidersStatus unknownNCT04341519
- Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 PatientsStatus unknownNCT04324047